An Introduction to Rule-based Modeling of Immune Receptor Signaling by Sekar, John A. P. & Faeder, James R.
An	Introduction	to	Rule-based	Modeling	of	
Immune	Receptor	Signaling	
John	A.P.	Sekar,	James	R.	Faeder	
Department	of	Computational	and	Systems	Biology,	University	of	Pittsburgh	School	of	
Medicine,	Pittsburgh,	Pennsylvania.	
1. Introduction	
It	is	well	known	that	cells	process	external	and	internal	signals	through	chemical	interactions	(Lodish	et	
al.,	2008;	Nelson	and	Cox,	2013).	Cells	that	constitute	the	immune	system	can	be	of	many	different	types,	
such	as	antigen	presenting	cell,	T-cell,	B-cell,	mast	cell,	etc.	Each	of	these	cells	can	have	different	functions,	
such	as	adaptive	memory	or	inflammatory	response,	and	the	type	and	functionality	of	the	cell	is	largely	
determined	by	the	type	and	number	of	receptor	molecules	on	the	cell	surface	and	the	specific	intracellular	
signaling	 pathways	 activated	 by	 those	 receptors	 (Owen	 et	 al.,	 2013).	 Given	 a	 particular	 biochemical	
signaling	 system	 in	 a	 particular	 immune	 cell,	 explicitly	 modeling	 and	 simulating	 kinetic	 interactions	
between	 molecules	 allows	 us	 to	 pose	 questions	 about	 system	 dynamics	 under	 various	 conditions	
(Aldridge	et	al.,	2006).	A	model	that	recapitulates	current	experimental	data	can	then	be	used	to	predict	
the	results	of	future	experiments	and	perturbations,	and	this	cycle	of	model	prediction	and	verification	
can	lead	to	a	better	understanding	of	the	system	and	potential	clinical	applications	(Kitano,	2002).	The	
promise	of	a	mechanistic	understanding	has	 led	 to	 the	enthusiastic	application	of	chemical	kinetics	 to	
biochemical	 signaling	 systems,	 but	 it	 has	 been	 limited	 by	 the	 complexity	 of	 the	 systems	 under	
consideration	(Hlavacek	et	al.,	2003;	Borisov	et	al.,	2005).		Rule-based	modeling	is	an	approach	to	building	
and	simulating	chemical	kinetic	models	that	addresses	this	complexity	(Sekar	and	Faeder,	2012;	Chylek	et	
al.,	2013).	BioNetGen	(Hlavacek	et	al.,	2006;	Faeder	et	al.,	2009),	Kappa	(Danos	et	al.,	2007a,	2007b)	and	
Simmune	(Meier-Schellersheim	et	al.,	2006;	Zhang	et	al.,	2013)	are	some	of	the	more	widely-used	rule	
based	frameworks.	PySB	provides	a	python	framework	for	rule-based	modeling	that	uses	BioNetGen	or	
Kappa	to	generate	models	(Lopez	et	al.,	2013).	In	this	chapter,	we	will	explore	the	origins	of	complexity	in	
macromolecular	 interactions,	 show	how	 rule-based	modeling	 can	be	used	 to	 address	 complexity,	 and	
demonstrate	the	construction	of	a	model	in	the	BioNetGen	framework.	Open	source	BioNetGen	software	
and	documentation	are	available	at	http://bionetgen.org.	We	highly	 recommend	 that	users	 start	with	
RuleBender	(Smith	et	al.,	2012),	which	is	a	graphical	user	interface	for	BioNetGen	that	has	text	highlighting	
and	syntax	checking	as	well	as	interactive	visualization	and	simulation	capabilities.	
2. Origins	of	Complexity	
For	this	chapter,	we	will	consider	a	model	of	signaling	from	the	FcεRI	receptor	present	in	mast	cells	(Faeder	
et	al.,	2003),	which	we	will	refer	to	as	“the	FcεRI	model.”	Degranulation	of	mast	cells	and	basophils	plays	
an	important	role	in	allergic	immune	response,	and	this	is	initiated	by	signaling	from	FcεRI	receptors	on	
these	cells.	These	receptors	recognize	the	Fc	portion	of	IgE	antibodies	whose	Fab	portion	binds	antigens.	
The	activating	ligand	molecule	is	a	single	antigen	bound	to	multiple	antibodies,	thereby	providing	multiple	
Fc	sites	to	bind	FcεRI	receptors.	When	two	or	more	receptors	are	crosslinked	by	a	ligand,	a	sequence	of	
binding	 and	 phosphorylation	 events	 on	 the	 cytoplasmic	 side	 lead	 to	 activation	 of	 Syk	 kinase,	 which	
subsequently	 promotes	 the	 degranulation	 response	 (Siraganian	 et	 al.,	 2010).	 Faeder	 et	 al.	 (2003)	
examined	 the	dose	 response	of	Syk	activation	 to	 ligand	concentration	and	use	 four	molecule	 types:	a	
ligand,	the	FceRI	receptor,	Lyn	kinase	and	Syk	kinase.		
The	structural	assumptions	underlying	the	FcεRI	model	are	summarized	in	Figure	1a.	The	model	considers	
a	bivalent	ligand,	i.e.	one	with	two	Fc	sites	for	the	FcεRI	receptor.	The	receptor	itself	is	made	up	of	three	
chains:	the	𝛼	subunit	capable	of	binding	ligand,	the	𝛽	subunit	capable	of	binding	Lyn	and	the	𝛾	subunit	
capable	of	binding	Syk.	The	𝛽	and	𝛾	subunits	have	phosphorylation	sites	present	on	them,	and	we	assume	
that	the	functional	states	for	the	subunits	are	‘phosphorylated’	and	‘unphosphorylated.’	On	Lyn	kinase,	
we	consider	two	domains:	a	unique	domain	U	capable	of	binding	unphosphorylated	𝛽	subunit	of	receptor	
weakly,	and	an	SH2	domain	that	binds	the	phosphorylated	𝛽	subunit	strongly.	On	Syk	kinase,	we	consider	
three	 domains:	 a	 tSH2	 domain	 that	 binds	 phosphorylated	 𝛾	 subunit	 of	 receptor,	 a	 group	 of	
phosphorylation	motifs	on	the	activation	loop	of	the	Syk	kinase,	and	another	group	of	phosphorylation	
motifs	present	in	a	linker	region	on	Syk.	Activation	loop	phosphorylation	is	known	to	activate	the	kinase	
activity	 of	 Syk,	 whereas	 linker	 phosphorylation	 is	 presumed	 to	 have	 a	 modulatory	 effect.	 Syk	
phosphorylated	on	activation	loop	can	be	considered	the	output	of	this	system.	
The	reaction	mechanisms	in	the	model	are	summarized	in	Figure	1b.	A	dimer	is	formed	by	the	bivalent	
ligand	 crosslinking	 two	 receptors.	 Lyn	 binds	 weakly	 using	 the	 U	 domain	 and	 in	 the	 dimer	 form,	 it	
phosphorylates	the	𝛽	and	𝛾	subunits	of	the	adjacent	receptor.	The	phosphorylated	𝛽	domain	can	bind	
Lyn	 strongly	 via	 its	 SH2	 domain,	 which	 leads	 to	 increased	 Lyn-dependent	 phosphorylation.	 The	
phosphorylated	𝛾	domain	recruits	Syk,	and	recruited	Syk	is	phosphorylated	in	two	ways:	on	the	activation	
loop	by	Lyn	recruited	to	the	adjacent	receptor,	and	on	the	linker	region	by	Syk	recruited	to	the	adjacent	
receptor.	The	model	makes	conservative	assumptions	about	how	binding	processes	influence	each	other,	
i.e.	it	assumes	that	ligand-binding,	Lyn-binding	and	Syk-binding	events	can	happen	independent	of	each	
other	as	long	as	the	receptor	they	bind	to	has	the	necessary	binding	site	exposed.	Similarly,	it	assumes	
that	 Syk	 binding	 to	 receptor	 happens	 independent	 of	 its	 phosphorylation	 status.	 Given	 additional	
information,	it	is	possible	to	modify	these	assumptions	in	the	rule-based	model	and	add	context	to	binding	
events,	but	we	will	use	the	originally	published	assumptions	(Faeder	et	al.,	2003)	for	the	purposes	of	this	
chapter.	
The	independence	assumptions	lead	to	many	valid	combinations	of	molecules,	states	and	bonds	that	can	
coexist,	and	this	leads	to	a	large	state	space	of	chemical	species,	i.e.	a	large	number	of	unique	molecules	
and	complexes.	This	phenomenon	is	called	combinatorial	complexity	(Hlavacek	et	al.,	2003)	and	Figure	2	
shows	an	accounting	of	the	possible	species	that	can	form	in	the	FcεRI	model	given	the	interactions	in	the	
model.	 There	 are	 4	 variants	 of	 the	 free	 Syk	 molecule	 not	 bound	 to	 anything	 else,	 because	 of	 two	
phosphorylation	motifs	on	Syk	 that	 can	each	be	phosphorylated	or	unphosphorylated	 (2x2).	 Similarly,	
there	are	4	variants	of	free	receptor	molecule	not	bound	to	anything	else,	because	of	two	subunits	that	
can	each	be	phosphorylated	or	unphosphorylated	(2x2).	All	4	free	receptors	can	bind	Lyn,	 leading	to	4	
receptor-Lyn	complexes.	Two	free	receptors	are	𝛾-phosphorylated	and	can	bind	four	forms	of	Syk	each,	
leading	to	8	receptor-Syk	complexes	(2x4).	Similarly,	two	receptor-Lyn	complexes	have	a	phosphorylated	𝛾	subunit	that	can	bind	4	forms	of	Syk,	leading	to	8	receptor-Lyn-Syk	complexes	(2x4).	In	total	there	are	
24	different	complexes	in	which	there	is	exactly	one	receptor	and	zero	ligand,	which	we	call	monomeric	
receptor	 complexes	without	 ligand.	 By	 binding	 a	 free	 ligand	 to	 each	 of	 these,	we	 get	 24	monomeric	
receptor	 complexes	 with	 ligand.	 Dimers,	 which	 are	 formed	 by	 a	 ligand	 crosslinking	 two	 monomeric	
receptor	 complexes,	 can	 be	 symmetric	 or	 asymmetric.	 On	 the	 symmetric	 dimer,	 the	 two	 recruited	
monomeric	receptors	are	identical,	and	since	there	are	24	monomeric	receptor	types,	there	are	also	24	
symmetric	dimers.	On	the	asymmetric	dimer,	the	two	recruited	monomeric	receptors	are	dissimilar,	and	
there	are	276	such	dissimilar	pairs	available	(24*23/2),	leading	to	276	asymmetric	dimer	complexes.	In	
total	there	are	48	monomeric	receptor	complexes	(24+24)	and	300	dimer	complexes	(24+276).	Including	
free	ligand,	free	Lyn	and	4	forms	of	free	Syk,	there	are	354	chemical	species	in	the	system.	
3. Molecules	in	BioNetGen	are	structured	objects	that	can	combine	to	
form	complexes	
Rule-based	models	can	handle	the	combinatorics	of	 large	chemical	state	spaces	automatically	without	
manual	curation.	In	the	standard	reaction	formalism,	each	chemical	species	needs	to	have	a	unique	label	
assigned	by	the	modeler,	but	in	the	rule-based	formalism,	each	chemical	species	is	a	structured	graph	that	
can	 be	 synthesized	 by	 a	 formal	 algorithm	 subject	 to	 the	 rules	 specified	 in	 the	model.	 The	 structural	
building	 blocks	 for	 chemical	 species	 in	 a	 BioNetGen	model	 are	molecules,	 components	 of	molecules,	
internal	states	of	components,	and	bonds	between	pairs	of	components.	The	molecule types	block	
in	a	BioNetGen	model	file	specifies	the	types	of	molecules,	components	and	internal	states. 
begin molecule types 
 Lig(fc,fc) 
 Rec(alpha,beta~0~P,gamma~0~P) 
 Lyn(U,SH2) 
 Syk(tSH2,linker~0~P,aloop~0~P) 
end molecule types 
	
Here,	Lig,	Rec,	Lyn	and	Syk	refer	to	the	names	of	the	types	of	molecules.	The	number	and	type	of	
each	molecular	component	is	specified	within	brackets.	The	ligand	Lig	has	two	components	named	fc	
referring	to	binding	sites	for	receptor.	Since	both	sites	are	named	identically,	any	attribute	applicable	to	
fc	anywhere	in	the	model	will	be	equivalently	applied	to	both	sites	on	Lig.	The	receptor	Rec	has	three	
components	 alpha,	 beta	 and	 gamma,	 and	 the	 ~{string}	 notation	 denotes	 the	 internal	 states	
available	 to	 beta	 and	 gamma	 components,	 which	 are	 ~0	 representing	 unphosphorylated	 and	 ~P	
representing	phosphorylated	respectively.	Lyn	 is	defined	to	have	two	components	U	and	SH2.	Syk	 is	
defined	to	have	three	components	tSH2,	linker	and	aloop,	with	linker	and	aloop	being	allowed	
to	take	unphosphorylated	and	phosphorylated	states.	
All	molecular	variants	that	exist	in	the	model	are	derived	from	permutations	of	internal	states	defined	in	
the	molecule types	block.	In	this	case,	Lyn	has	one	only	one	variant,	Lyn(U,SH2),	whereas	the	
receptor	 has	 four	 possible	 variants,	 Rec(alpha,beta~0,gamma~0), 
Rec(alpha,beta~0,gamma~P), Rec(alpha,beta~P,gamma~0) and 
Rec(alpha,beta~P,gamma~P) respectively.	Complexes	are	synthesized	by	joining	molecules	using	
bonds	between	pairs	of	 components,	which	 is	denoted	using	 the	!	 symbol	 followed	by	a	bond	 index.	
Shown	below	are	three	species	of	increasing	size:	
Rec(alpha,beta~0,gamma~0) 
Rec(alpha,beta~0!1,gamma~0).Lyn(U!1,SH2) 
Rec(alpha,beta~0!1,gamma~P!2).Lyn(U!1,SH2).Syk(tSH2!2,aloop~0,linker~0) 
The	first	species	contains	a	single	Rec	molecule	with	nothing	bound	and	all	sites	unphosphorylated	(i.e.	
with	states	~0).	The	second	species	has	two	molecules	Lyn	and	unphosphorylated	Rec	and	these	are	
bound	via	their	respective	U	and	beta	components.	The	bond	label	!1	is	placed	adjacent	to	beta	and	U	
components	 to	 show	 that	 there	 is	 a	 binding	 interaction	 between	 them.	 The	 third	 species	 has	 three	
molecules		Lyn,	Syk	and	Rec	that	are	bound	together	by	a	bond	!1	between	U	and	beta	components	
and	a	bond	!2	between	gamma	and	tSH2	components,	with	gamma	phosphorylated	as	indicated	by	the	
state	~P.	Arbitrarily	large	complexes	can	be	constructed	in	this	manner	and	the	process	can	be	automated	
as	discussed	below.	
4. Patterns	select	species	with	shared	features	
The	 advantage	 of	 using	 a	 structured	 graph	 specification	 for	 chemical	 species	 such	 as	 molecules	 and	
complexes	 is	 that	 it	 is	 possible	 to	 refer	 to	 multiple	 species	 by	 specifying	 a	 shared	 subgraph.	 Such	 a	
subgraph	is	called	a	pattern	in	BioNetGen	and	serves	as	a	tool	to	partition	the	state	space	into	matching	
versus	 non-matching	 chemical	 species	 without	 having	 to	 enumerate	 the	 full	 state	 space	 of	 species.	
Because	 both	 patterns	 and	 chemical	 species	 are	 graphs	 constructed	 from	 the	 same	 fundamental	
elements,	one	can	define	patterns	to	match	any	set	of	structural	features	in	any	arrangement	of	molecules	
within	a	complex,	and	the	specified	pattern	may	be	matched	by	any	number	of	molecules	and	complexes.		
Shown	below	is	a	pattern	that	selects	free	ligand,	i.e.	ligand	with	both	sites	unbound.	
Lig(fc,fc) 
This	pattern	matches	exactly	one	chemical	species,	shown	below.	The	matches	of	the	pattern	to	species	
are	shown	in	red.	Figure	3a	shows	a	visualization	of	the	match	between	pattern	and	species.	
Lig(fc,fc) 
Next,	we	show	a	pattern	that	selects	receptors	with	an	unbound	alpha	domain.	
Rec(alpha) 
Note	that	we	have	omitted	the	other	receptor	components	beta	and	gamma,	which	means	that	their	
binding	and	modification	states	will	not	affect	selection	of	matching	species.	For	example,	the	pattern	
Rec(alpha)	selects	each	of	the	following	three	species,	visualized	in	Figure	3b:	
Rec(alpha,beta~0,gamma~0) 
Rec(alpha,beta~0!1,gamma~0).Lyn(U!1,SH2) 
Rec(alpha,beta~0!1,gamma~P!2).Lyn(U!1,SH2).Syk(tSH2!2,aloop~0,linker~0) 
Next,	we	show	a	pattern	that	selects	ligand-containing	complexes	in	which	one	site	on	the	ligand	is	free,	
but	the	other	is	bound	to	a	receptor:	
Lig(fc,fc!0).Rec(alpha!0) 
Shown	below	are	three	examples	of	complexes	with	matches	shown	in	green,	also	visualized	in	Figure	3c.	
Lig(fc,fc!0).Rec(alpha!0,beta~0,gamma~0) 
Lig(fc,fc!0).Rec(alpha!0,beta~0!1,gamma~0).Lyn(U!1,SH2) 
Lig(fc,fc!0).Rec(alpha!0,beta~0!1,gamma~P!2).Lyn(U!1,SH2). 
       Syk(tSH2!2,aloop~0,linker~0) 
In	the	full	model,	the	patterns	Rec(alpha)	and	Lig(fc,fc!0).Rec(alpha!0) will	match	all	24	
monomeric	 receptor	 complexes	 and	 24	 ligand-bound	monomers	 respectively,	 whose	 accounting	 was	
performed	in	Figure	2.	
The	BioNetGen	pattern	 syntax	enables	 flexible	 selection	of	different	 chemical	 species	based	on	which	
structural	features	are	specified.	As	discussed	previously,	omitting	a	component	implies	that	neither	its	
binding	nor	internal	states	will	be	used	as	match	criteria.	It	is	also	possible	to	specify	the	binding	state	but	
not	 the	 internal	 state,	 e.g.,	Rec(beta)	will	match	 complexes	with	 an	unbound	beta	 domain,	both	
beta~0	and	beta~P.	Similarly,	it	is	also	possible	to	specify	the	internal	state	if	present,	but	leave	the	
binding	 state	 unspecified	 (!?)	 or	 partially	 specified	 (!+).	Here,	!?	matches	 both	bound	 and	unbound	
states	 of	 components,	 and	 !?	 matches	 all	 bonds	 with	 that	 component	 type	 irrespective	 of	 binding	
partner.	
5. Reaction	rules	define	interactions	between	molecules	and	can	
generate	reactions	
Reaction	mechanisms	specified	in	the	BioNetGen	language	are	called	reaction	rules.	A	reaction	rule	has	
five	 parts:	 (1)	 an	 optional	 label,	 (2)	 patterns	 specifying	 the	 properties	 reactants	 must	 possess	 to	 be	
selected	by	the	rule,	(3)	an	arrow	indicating	whether	or	not	the	rule	is	reversible,	(4)	patterns	specifying	
the	products	to	indicate	how	reactants	are	transformed	by	the	rule,	and	(5)	a	set	of	rate	laws	that	govern	
the	kinetics	of	each	reaction	generated	by	the	rule.	Shown	below	is	a	reaction	rule	involving	the	three	
patterns	specified	above:	
R1:  Lig(fc,fc) + Rec(alpha) <-> Lig(fc,fc!0).Rec(alpha!0)     kp1,km1 
The	rule	is	visualized	in	Figure	4a.	Here,	R1	is	the	name	of	the	rule.	The	rule	is	bidirectional	because	of	the	
use	 of	 the	 reversible	 arrow	 (<->).	 Lig(fc,fc)	 and	 Rec(alpha)	 are	 the	 reactant	 patterns.	
Lig(fc,fc)	specifies	that	both	sites	on	ligand	are	unbound,	so	it	will	match	the	free	ligand	species.	
Rec(alpha)	matches	 receptors	with	 an	 unbound	 alpha	 domain,	 so	 it	will	match	 all	 24	monomeric	
receptor	complexes	that	do	not	have	a	bound	ligand.	The	pattern	Lig(fc,fc!0).Rec(alpha!0)	is	
the	product	of	the	rule.	By	examining	it	relative	to	the	reactants,	BioNetGen	infers	that	the	action	of	the	
rule	is	to	add	a	bond	between	an	available	fc	site	and	alpha	subunit	(highlighted	in	red)	and	can	apply	
the	rule	to	all	combinations	of	matched	reactant	species.	Since	Lig(fc,fc)	and	Rec(alpha)	match	
1	and	24	species	respectively,	the	reaction	rule	generates	1x24	ligand-binding	reactions.	Application	of	
the	rule	in	reverse	also	generates	all	corresponding	ligand	dissociation	reactions,	i.e.	the	24	reactions	that	
result	in	free	ligand	and	a	monomeric	receptor	complex.	kp1	and	km1	are	the	rate	constants	applicable	
to	reactions	generated	from	the	forward	and	reverse	directions	of	the	rule	respectively.	
Unidirectional	rules	can	be	specified	by	using	the	forward	arrow	(->)	and	specifying	only	one	rate	constant.	
An	 example	 of	 a	 unidirectional	 rule	 is	 shown	 below,	 modeling	 transphosphorylation	 of	 receptor	 by	
recruited	Lyn:	
R4: Lyn(U!1).Rec(beta!1,alpha!2).Lig(fc!2,fc!3).Rec(alpha!3,beta~0)-> \ 
Lyn(U!1).Rec(beta!1,alpha!2).Lig(fc!2,fc!3).Rec(alpha!3,beta~P) pLb 
The	rule	named	R4	is	visualized	in	Figure	4b.	Here,	the	reactant	pattern	shows	four	molecules	connected	
by	 three	bonds:	 a	 ligand	bound	 to	 two	 receptors	 and	Lyn	 bound	 to	one	of	 the	 receptors.	 The	other	
receptor	is	phosphorylated	on	the	free	beta	component	i.e.	transformed	from	~0	on	the	reactant	side	
to	~P	on	the	product	side	(shown	in	red).	The	gamma	components	on	the	receptors	are	omitted	since	
they	do	not	explicitly	affect	this	process.	pLb	is	a	parameter	that	specifies	the	first	order	phosphorylation	
rate	constant.	
Because	patterns	used	in	rules	can	get	large,	it	helps	to	sort	the	specified	structures	into	reaction	center	
and	 reaction	 context	 to	 aid	 their	 comprehension	 and	 discussion.	 The	 reaction	 center	 is	 the	 set	 of	
structures	that	are	modified	by	the	rule	and	thereby	defines	the	action	of	the	rule.	The	reaction	center	of	
rule	R1	specified	above	is	the	set	of	binding	sites	fc	and	alpha	on	the	reactant	side,	and	the	fc-alpha	
bond	on	the	product	side.	The	reaction	center	of	rule	R4	is	the	internal	state	of	the	beta	component	that	
was	modified	from	~0	to	~P.	The	reaction	context	includes	the	remaining	structures	that	are	specified	in	
the	rule	but	are	not	modified	by	 the	rule.	This	establishes	 the	set	of	 local	conditions	under	which	 the	
action	of	 the	 rule	 is	allowed	 to	happen.	For	 rule	R1,	 the	 reaction	context	 is	 the	presence	of	a	 second	
unbound	fc	 site.	 For	 rule	 R4,	 the	 reaction	 context	 is	 the	 unbound	 status	 of	 the	beta	 site	 that	was	
phosphorylated,	 and	 the	 set	 of	 three	 bonds	 that	 constitute	 the	 Lyn-recruited-to-dimer	 configuration.	
Given	a	rule,	the	reaction	center	is	identified	by	the	differences	between	the	reactants	and	products	of	
the	rule	and	the	reaction	context	is	identified	by	structures	preserved	on	both	reactants	and	products.	
Rules	interact	with	each	other	when	the	reaction	center	of	one	rule	overlaps	with	the	reaction	context	of	
another.	For	example,	the	fc-alpha	bond	that	is	formed	in	rule	R1	is	necessary	for	the	Lyn-recruited-
to-dimer	 configuration	 that	 is	 context	 for	 rule	 R4,	 implying	 that	 R1	 enables	 R4.	 These	 interactions	
constitute	 the	 flow	 of	 signal	 through	 the	 system	 and	 reaction	 rules	 enable	 reconstituting	 a	 signaling	
pathway	from	the	fundamental	kinetic	processes.	The	FcεRI	model	used	in	this	chapter	has	19	reaction	
rules	modeling	free	ligand	binding	(1),	receptor	crosslinking	by	ligand	(1),	Lyn	binding	to	receptor	(2),	Syk	
binding	to	receptor	(1),	transphosphorylation	by	Lyn	on	receptor	and	Syk	sites	(6),	transphosphorylation	
by	Syk	on	Syk	(2)	and	background	dephosphorylation	processes	(6)	respectively.	In	the	BioNetGen	model	
file,	rules	are	listed	in	the	reaction rules	block:	
begin reaction rules 
# Ligand-receptor binding       
R1: Rec(alpha) + Lig(fc,fc) <-> Rec(alpha!1).Lig(fc!1,fc)  kp1, km1 
 
# Receptor-aggregation 
R2: Rec(alpha) + Lig(fc,fc!0).Rec(alpha!0) <-> \ 
Rec(alpha!1).Lig(fc!1,fc!0).Rec(alpha!0)  kp2, km2 
 
# Constitutive Lyn-receptor binding 
R3: Rec(beta~0) + Lyn(U,SH2) <-> Rec(beta~0!1).Lyn(U!1,SH2)  kpL, kmL 
 
# Transphosphorylation of beta by constitutive Lyn 
R4: Lyn(U!1).Rec(beta!1,alpha!2).Lig(fc!2,fc!3).Rec(alpha!3,beta~0)->\  
Lyn(U!1).Rec(beta!1,alpha!2).Lig(fc!2,fc!3).Rec(alpha!3,beta~P) pLb 
... 
... 
end reaction rules 
Text	beginning	with	#	and	ending	on	a	line	break	can	be	used	to	provide	useful	comments	and	annotations	
anywhere	in	the	model,	and	they	are	ignored	by	the	BioNetGen	processor.	The	character	\	can	be	used	
to	 split	 rules	 across	 lines	 when	 the	 rules	 get	 really	 large.	Within	 patterns,	 the	 order	 of	 components	
between	brackets	does	not	matter.	Similarly,	the	specific	bond	index	used	for	bonds	does	not	matter,	as	
long	as	the	intended	pair	of	components	have	the	same	unique	bond	index.	BioNetGen	also	allows	more	
complex	specifications	for	the	rate	law	that	are	out	of	the	scope	of	this	chapter	(Chylek	et	al.,	2015).	
6. Observables	and	functions	define	the	outputs	of	the	model	
There	are	two	types	of	outputs	in	the	BioNetGen	model:	measurements	of	species	concentrations	called	
observables	and	functions	of	those	observables.	In	a	rule-based	model,	pattern	matching	can	be	exploited	
to	generate	sums	of	species	automatically.	 	Observables	are	of	 two	types:	counting	unique	complexes	
only,	 or	 counting	 individual	 matches	 of	 patterns	 within	 complexes.	 These	 are	 specified	 using	 the	
Species	and	Molecule	keywords	respectively	within	the	observables	block.	For	the	FcεRI	model,	we	
are	interested	in	the	partitioning	of	individual	receptor	and	Syk	molecules	into	various	configurations,	so	
we	will	only	use	Molecule	observables.	The	observables	block	used	for	this	model	is:	
begin observables 
 Molecules Dimer  Rec(alpha!1).Lig(fc!1,fc!2).Rec(alpha!2) 
Molecules  TotalRec Rec() 
 Molecules ActiveSyk Syk(aloop~P) 
Molecules TotalSyk Syk() 
Molecules BetaP  Rec(beta~P!?) 
Molecules GammaP Rec(gamma~P!?) 
end observables 
Here,	 the	 pattern	 Rec(alpha!1).Lig(fc!1,fc!2).Rec(alpha!2)	 counts	 all	 ligand-
crosslinked	dimer	species,	of	which	there	are	300	types	in	the	model.	Since	it	is	a	Molecule	observable	
and	the	pattern	will	match	twice	into	each	dimer,	each	dimer	will	be	counted	twice	and	the	resultant	sum	
will	 be	 the	 total	 number	of	 receptors	 in	 dimers.	 The	pattern	Syk(aloop~P)	 counts	 number	of	 Syk	
molecules	 with	 phosphorylated	 activation	 loop,	 and	 the	 patterns	 Rec(beta~P!?)	 and	
Rec(gamma~P!?)	count	receptor	molecules	that	are	respectively	phosphorylated	on	beta	and	gamma	
respectively.	Here	!?	was	used	to	ensure	that	the	observable	counted	both	unbound	and	bound	forms	of	
beta	 and	gamma	 components.	 This	 was	 not	 necessary	 for	aloop	 since	 there	 are	 no	 binding	 rules	
specified	for	aloop.	Also,	the	two	observables	for	𝛽	and	𝛾	phosphorylation	will	have	some	species	that	
are	counted	for	both	observables,	since	receptors	can	be	phosphorylated	on	both	beta	and	gamma	sites.	
Finally,	observables	Rec()	 and	Syk()	 simply	count	all	 receptor	molecules	and	Syk	molecules	 in	 the	
system	respectively,	since	no	component-matching	terms	are	specified.	
Functions	of	observables	can	be	defined	in	the	functions	block.	For	the	FcεRI	model,	we	will	consider	
three	outputs:	 fraction	of	 receptor	 in	dimers,	 fraction	of	Syk	 that	 is	active	 (i.e.	phosphorylated	on	the	
activation	loop),	and	ratio	of	phosphorylated	gamma	and	beta	sites	on	receptors.	
begin functions 
 DimerFraction    Dimer/TotalRec 
 AutoPhosphorylatedSykFraction ActiveSyk/TotalSyk 
 GammaBetaPhosphorylationRatio GammaP/BetaP 
end functions 
7. Parameterizing	a	model	requires	geometric	terms,	rate	constants	and	
species	concentrations	
Parameterizing	 a	 BioNetGen	model	 requires	 a	 self-consistent	 set	 of	 units	 for	 concentrations	 and	 rate	
constants.	For	this	particular	model,	we	have	only	used	unimolecular	and	bimolecular	reactions	and	we	
would	 like	to	measure	protein	fluxes	 in	molecules	per	second.	We	will	 limit	ourselves	to	considering	a	
single	cell	surrounded	by	a	milieu	of	freely	diffusing	ligand.	We	will	also	specify	units	as	comments	using	
#	symbol	in	order	to	be	clear	to	the	modeler.	These	comments	will	be	ignored	by	BioNetGen.	
First,	we	will	need	to	specify	fundamental	constants	such	as	𝜋	and	Avogadro’s	number	𝑁&	to	be	used	in	
our	calculations.	
NA  6.023e23 # units: molecules/mol 
pi  3.14159 # no unit 
Next,	we	will	need	to	specify	concentrations	of	proteins	and	ligands	that	reflect	the	experimental	setup.	
Ligand	concentration	for	this	system	is	typically	provided	in	nanomolar	values	and	has	to	be	converted	to	
molecule	numbers.	One	molar	concentration	is	one	mol/liter,	so	the	conversion	is	achieved	by	multiplying	
molar	concentration	with	Avogadro	constant	and	volume	of	the	external	milieu,	which	in	turn	is	estimated	
from	a	cell	density	of	million	cells	per	milliliter.	A	conversion	factor	of	1e3	is	required	to	convert	milliliter	
volumes	to	liters.	
celldensity  1e6*1e3    # units: cells/L 
vol_ext  1/celldensity  # units: L/cell*(1 cell) = L 
Lig_conc  1e-9    # units: molar 
Lig_tot  Lig_conc*vol_ext*NA # units: molecules 
Receptor	numbers	are	usually	provided	as	molecule	numbers	per	cell,	so	they	are	used	directly.	Lyn	and	
Syk	numbers	are	estimated	relative	to	receptor	numbers,	so	they	are	specified	using	proportional	factors.	
Rec_tot  4e5   # units: molecules 
fLyn   0.07 
fSyk   1 
Lyn_tot  fLyn*Rec_tot 
Syk_tot  fSyk*Rec_tot 
 
Unimolecular	rate	constants	such	as	those	for	phosphorylation,	dephosphorylation	and	bond	dissociation	
are	usually	known	or	estimated	 in	per	second	units,	 so	 they	can	be	used	directly.	Here,	we	show	one	
example	of	each:	ligand	dissociation	constant	(km1),	rate	of	𝛽-phosphorylation	by	Lyn	(pLb)	and	rate	of	
background	dephosphorylation	at	the	membrane	(dm).	
km1  0.01  # units: /s 
pLb  30 # units: /s 
dm  20 # units: /s 
Bimolecular	association	rate	constants	are	usually	provided	in	units	of	per	molar	per	second.	Converting	
to	per	molecule	per	second	requires	dividing	by	Avogadro	constant	and	the	respective	volume	in	which	
the	bimolecular	association	occurs.	We	show	three	examples	below:	association	rate	constant	for	free	
ligand	which	needs	to	be	scaled	by	external	volume	(kp1),	association	rate	constant	for	ligand	crosslinking	
which	occurs	in	the	membrane	(kp2),	and	association	rate	constant	for	Lyn	binding	to	unphosphorylated	
𝛽	site	which	occurs	 in	the	cytoplasm	(kpL).	For	a	simple	BioNetGen	model,	scaling	of	association	rate	
constants	can	be	performed	manually,	but	for	more	complicated	systems	it	is	recommended	to	use	the	
compartmental	 extension	 to	 the	 BioNetGen	 framework	 (Harris	 et	 al.,	 2009a)	 where	 such	 scaling	 is	
performed	automatically.	
kp1 1e7/(NA*vol_ext)  # units: /molecule/s 
kp2 1e6/(NA*vol_mem)  # units: /molecule/s 
kpL 4.2e7/(NA*vol_cell) # units: /molecule/s 
External	 volume	was	calculated	previously	 from	cell	density.	Volume	of	 the	membrane	 is	 specified	by	
multiplying	surface	area	of	the	cell	with	an	effective	width	of	10	nanometers	(Harris	et	al.,	2009a).	Volume	
and	surface	area	of	the	cell	are	both	estimated	by	assuming	a	spherical	cell	with	7	micron	radius.	Cubic	
meter	volume	is	converted	to	liter	units	by	multiplying	by	1e3.	
rad_cell 7e-6     # units: meter 
vol_cell 1e3*(4/3)*pi*rad_cell^3  # units: L 
surf_area 4*pi*rad_cell^2   # units: squared meter 
eff_width 10e-9     # units: meter 
vol_mem 1e3*surf_area*eff_width # units: L 
Here,	 the	 association	 constant	 for	 membrane	 reactions	 (kp2)	 was	 specified	 as	 a	 three-dimensional	
association	 rate	 constant	 (units:	 per	 molar	 per	 second,	 i.e.	 per	 “mol	 per	 liter”	 per	 second),	 which	
necessitates	a	conversion	of	the	two-dimensional	surface	area	of	the	membrane	to	a	three-dimensional	
volume	using	an	effective	width	term.	An	alternate	parameterization	would	be	to	use	a	two	dimensional	
association	rate	constant	(units:	per	“mol	per	squared	meter”	per	second),	in	which	case	it	is	sufficient	to	
multiply	by	surface	area	only	and	not	the	effective	width.		
The	parameters	and	parameter	expressions	are	specified	in	the	parameters block	in	the	model	file.	
begin parameters 
 NA   6.023e23    # units: molecules/mol 
 pi   3.14159 
 rad_cell  7e-6     # units: meter 
 vol_cell  1e3*(4/3)*pi*rad_cell^3 # units: L 
celldensity  1e6*1e3    # units: cells/L 
vol_ext  1/celldensity  # units: L/cell*(1 cell)= L 
Lig_conc  1e-9    # units: molar 
Lig_tot  Lig_conc*vol_ext*NA # units: molecules 
 ... 
 ... 
end parameters 
Initial	concentrations	for	chemical	species	are	specified	in	the	seed species	block.	The	concentrations	
can	be	specified	in	terms	of	parameter	expressions	defined	in	the	parameters	block.	
begin seed species 
Lig(fc,fc)             Lig_tot 
Lyn(U,SH2)            Lyn_tot 
Syk(tSH2,linker~0,aloop~0)  Syk_tot 
Rec(alpha,beta~0,gamma~0)  Rec_tot 
end seed species 
In	the	seed	species	block,	only	fully	defined	molecules	and	complexes	must	be	specified.	In	other	words,	
every	molecule	should	have	every	component	present,	and	every	component	should	have	internal	and	
binding	states	clearly	specified.	For	this	model,	the	unbound	and	unphosphorylated	forms	of	all	molecules	
are	considered	to	be	the	seed	species.	Depending	on	how	the	system	is	simulated	the	remaining	species	
that	 can	occur	 in	 the	 system	will	 either	be	generated	by	 iterative	application	of	 the	 rules	 to	 the	 seed	
species	by	a	process	called	network	generation,	or	they	will	be	discovered	“on-the-fly”	as	the	system	is	
simulated	and	rules	modify	the	state	of	the	initial	species	(Faeder	et	al.,	2009).	
8. Model	actions	are	used	to	simulate	and	analyze	a	model	
The	complete	model	specification	has	blocks	for	parameters,	molecule	types,	reaction	rules,	observables	
and	seed	species,	and	is	stored	in	a	text	file	with	the	extension	“.bngl”.	Model	actions	are	appended	to	
the	end	of	the	model	file	in	order	to	call	tools	that	use	the	model	specification.	This	enables	the	specified	
model	to	be	converted	into	a	reaction	network,	simulated	using	multiple	available	methods,	exported	to	
other	frameworks,	visualized	at	different	resolutions,	and	also	scanned	over	parameter	ranges	to	reveal	
parameter	 sensitivity	 and	 bifurcation	 properties.	 A	 comprehensive	 actions	 and	 arguments	 guide	 is	
available	 at	 http://bionetgen.org.	 Here,	 we	 will	 discuss	 the	 use	 of	 three	 model	 actions:	
generate_network(),	simulate()	and	parameter_scan().	
8.1. A	reaction	network	can	be	generated	from	a	rule-based	model	
The	following	action	is	used	to	generate	a	reaction	network	whose	kinetics	are	equivalent	to	the	specified	
rule-based	model:	
generate_network({overwrite=>1}) 
This	 command	 iteratively	 applies	 the	 reaction	 rules	 to	 the	 seed	 species	 in	 order	 to	 generate	 new	
configurations	of	molecules	and	complexes	and	new	reactions	(Faeder	et	al.,	2009).	The	full	state	space	
of	 molecules,	 complexes	 and	 reactions	 is	 written	 to	 a	 file	 with	 the	 extension	 “.net”.	 The	 overwrite	
command	is	to	ensure	that	when	network	generation	is	performed	a	second	time,	any	past	generated	
networks	of	the	same	model	are	overwritten.	For	the	full	model	with	4	seed	species	and	19	rules,	the	
generate_network()	action	results	in	354	total	number	of	species	and	3680	reactions	(Faeder	et	al.,	
2003).		
One	of	 the	 features	of	 network	 generation	 is	 that	 the	 calculation	of	 statistical	 factors	 for	 reactions	 is	
handled	 automatically.	 For	 this	 reason,	 it	 is	 advantageous	 to	 build	 rule-based	models	 even	 for	 small	
reaction	 networks.	 We	 will	 show	 using	 simple	 examples	 how	 BioNetGen	 handles	 symmetry	 and	
multiplicity.	
Multiplicity	factors	are	needed	when	the	same	rule	can	be	applied	to	multiple	identical	parts	of	the	same	
reactant	species,	which	increases	the	effective	rate	by	a	factor.	For	example,	consider	the	molecule	types	
A(b)	and	B(a,a)	and	the	reaction	rule:	
R_AB:  A(b) + B(a) <-> A(b!1).B(a!1) kf,kr 
Now	consider	how	to	parameterize	 two	pairs	of	 reversible	binding	 reactions	generated	 from	the	 rule:	
binding	in	which	both	sites	on	B	are	free,	and	binding	in	which	one	of	the	sites	is	already	occupied.	
A(b) + B(a,a)    <->  A(b!1).B(a!1,a)    
A(b) + B(a,a!1).A(a!1) <->  A(b!2).B(a!2,a!1).A(b!1)  
The	pattern	B(a) matches	 to	species	B(a,a)	 in	 two	different	ways,	 i.e.	using	one	or	 the	other	 free	
binding	site.	This	means	that	the	effective	rate	of	the	reaction	is	double	what	one	would	expect	if	there	
was	only	one	free	site	on	B.	BioNetGen	would	detect	this	and	calculate	a	multiplicity	factor	of	2	for	the	
forward	reaction,	i.e.	
A(b) + B(a,a)    <->  A(b!1).B(a!1,a)   2*kf,kr 
For	 the	 second	pair	 of	 reactions,	 the	product	 pattern	A(b!1).B(a!1)	would	match	 twice	 into	 the	
species	A(b!2).B(a!2,a!1).A(b!1)since	there	are	two	identical	bonds	that	could	be	matched.	In	
this	case,	it	is	the	reverse	reaction	that	needs	to	be	multiplied	by	two,	since	the	presence	of	two	identical	
bonds	would	double	the	effective	rate	of	bond	breaking,	i.e.	
A(b) + B(a,a!1).A(a!1) <->  A(b!2).B(a!2,a!1).A(b!1) kf,2*kr 
Symmetry	 factors	 are	 needed	when	 the	 action	 of	 a	 rule	modifies	 at	 least	 two	 instances	 of	 a	 species	
simultaneously	and	 identically.	 For	example,	 consider	 the	molecule	 type	A(b~0~1)	 and	 the	 reaction	
rule:	
R_AA:  A(b) + A(b) -> A(b!1).A(b!1) kf 
The	reaction	rule	would	generate	three	reactions:	
A(b~0) + A(b~1) -> A(b~0!1).A(b~1!1)  
A(b~0) + A(b~0) -> A(b~0!1).A(b~0!1)  
A(b~1) + A(b~1) -> A(b~1!1).A(b~1!1)  
The	first	reaction	involves	two	different	reactant	species,	A(b~0)	and	A(b~1)respectively.	If	𝑁'and	𝑁(	
are	the	concentrations	of	A(b~0)	and	A(b~1)	respectively,	then	the	first	reaction	would	have	a	rate	of	𝑘*𝑁'𝑁(.		
The	second	reaction	operates	on	two	instances	of	the	same	species	A(b~0),	and	the	rate	is	determined	
to	be	𝑘* +, +,-(. 		,	where	+, +,-(. 	is	the	number	of	ways	to	select	two	molecules	out	of	𝑁'	molecules.	
For	high	𝑁',	𝑘* +, +,-(. 	≈ 𝑘* +,1. ,	but	a	rate	calculation	similar	to	the	first	reaction	would	only	yield	𝑘*𝑁'..	
Therefore,	a	factor	of	½		needs	to	be	applied	for	the	second	reaction	and	not	the	first.	Similarly,	the	third	
reaction	would	also	have	an	effective	rate	of	𝑘* +21. 	since	it	operates	on	two	instances	of	the	same	species	
A(b~1).	 Using	 graph	 isomorphism	 calculations	 (Hogg	 et	 al.,	 2014),	 BioNetGen	 estimates	 the	 correct	
symmetric	factor	adjustment	for	the	rate	constants	of	all	generated	reactions,	i.e.	
A(b~0) + A(b~1) -> A(b~0!1).A(b~1!1) kf  
A(b~0) + A(b~0) -> A(b~0!1).A(b~0!1) 0.5*kf 
A(b~1) + A(b~1) -> A(b~1!1).A(b~1!1) 0.5*kf 
8.2. Model	simulation	and	parameter	scans	reveal	insight	about	model	behavior	
The	specified	model	is	simulated	using	the	simulate()	action.	
simulate({method=>“ode”,t_end=>600,n_steps=>10,print_functions=>1})  
There	are	three	simulation	methods	that	can	be	used:	ODE	integration	(method=>“ode”),	Gillespie’s	
stochastic	 simulation	 algorithm	 (method=>“ssa”)	 (Gillespie,	 1977)	 and	 network-free	 stochastic	
simulation	(method=>“nf”).	The	ODE	and	SSA	methods	require	the	reaction	network	to	be	generated	
prior	to	simulation.	Network-free	simulation	uses	the	NFsim	algorithm	(Sneddon	et	al.,	2011),	which	was	
designed	to	exactly	simulate	kinetics	without	having	to	generate	the	full	reaction	network	in	advance	of	
the	 simulation.	 It	 generates	 results	 indistinguishable	 from	SSA	 and	 is	 useful	 for	models	 that	 generate	
disproportionately	 large	or	 infinite	 reaction	networks,	e.g.	models	with	oligomerization	 rules.	 In	 these	
networks,	the	number	of	unique	species	may	be	much	larger	than	the	actual	number	of	molecules	and	
complexes	present	during	simulation	and	only	a	fraction	of	the	state	space	may	be	populated	at	any	given	
time.	In	practical	terms,	the	network-free	simulation	method	typically	leads	to	faster	simulations	than	the	
corresponding	SSA	when	 the	number	of	possible	 species	 is	more	 than	 several	hundred	 to	a	 thousand	
(Sneddon	et	al.,	2011).		
The	 outputs	 of	 the	simulate()	 action	 are	 trajectory	 files	with	 extensions	 “.cdat”	 and	 “.gdat”.	 The	
“.cdat”	 file	 is	 generated	 by	 ODE	 and	 SSA	methods	 and	 contains	 concentrations	 of	 all	 molecules	 and	
complexes	over	time.		The	“.gdat”	file	is	generated	by	all	three	methods	and	contains	the	measured	values	
over	time	for	the	observables	defined	in	the	observables	block.	If	the	print_functions=>1	flag	
is	used,	then	the	“.gdat”	files	include	columns	for	each	of	the	specified	functions	in	the	functions	block	
also.	 The	 trajectory	 files	 can	 be	 imported	 into	 any	 data-processing	 software	 such	 as	Microsoft	 Excel,	
OpenOffice	Calc	or	MatLab.		
BioNetGen	provides	additional	actions	in	order	to	run	multiple	simulations	of	the	same	model	at	different	
parameter	 settings,	 such	 as	 setParameter(),	 setConcentrations(),	
resetConcentrations(),	 etc.	 It	 also	 provides	 a	 command	 to	 run	 batch	 simulations	 called	
parameter_scan(),	which	enables	scanning	over	a	particular	parameter	given	a	range	of	values	while	
keeping	other	parameters	constant.	parameter_scan()	takes	the	same	arguments	as	simulate()	
shown	above,	and	additionally	takes	arguments	that	specify	the	range	of	values	to	be	scanned	over	and	
the	reset	behavior	between	simulations.	The	results	of	parameter_scan()	are	stored	in	a	similar	form	
to	“.gdat”	and	“.cdat”	files,	but	with	the	extension	“.scan”.	Here,	we	show	how	parameter	scans	can	be	
used	to	elucidate	aspects	of	model	behavior.	
Shown	in	Figure	5	are	results	from	three	parameter	scans	for	each	of	the	three	outputs	defined	in	the	
functions	block,	i.e.	receptor	fraction	in	dimers,	ratio	of	𝛾/𝛽	phosphorylation	and	active	Syk	fraction.	
The	parameter	scan	over	ligand	concentration	was	performed	using	the	command:	
parameter_scan({method=>"ode",parameter=>"Lig_conc",par_min=>1e-12, \ 
par_max=>1e-,n_scan_pts=>50, log_scale=>1,reset_conc=>1, \ 
print_functions=>1,t_end=>600,n_steps=>5}) 
Note	that	method,	print_functions,	t_end	and	n_steps	arguments	are	used	the	same	as	in	the	
simulate()	command.	Additionally,	parameter	specifies	the	parameter	to	scan	over,	par_min	and	
par_max	 establish	 the	 minimum	 and	 maximum	 of	 the	 range	 of	 values	 to	 be	 used,	 n_scan_pts	
determines	how	many	points	 to	sample	within	 the	 range.	log_scale=>1	 sets	 the	spacing	between	
points	to	be	logarithmic,	which	enables	scanning	over	many	orders	of	magnitude.	For	smaller	ranges,	the	
default	setting	of	log_scale=>0	 is	used,	which	ensures	that	the	sampled	points	are	spaced	equally.	
reset_conc=>1	 ensures	 that	 when	 a	 new	 simulation	 is	 run,	 all	 parameter	 values	 and	 species	
concentrations	 are	 reset	 instead	 of	 being	 carried	 over	 from	 the	 previous	 simulation.	 In	 the	
parameter_scan()	command	shown	above,	we	enable	scanning	over	ligand	concentration	from	1e-
12	M	to	1e-3	M.	The	other	two	parameter_scan()	methods	shown	below	scan	over	Lyn/receptor	
ratio	and	Syk/receptor	ratio	between	the	range	of	0.01	to	10	and	use	the	same	remaining	arguments	as	
the	first	one.	Action	statements	can	also	be	split	across	multiple	lines	using	the	\	character.	
parameter_scan({parameter=>"fLyn",par_min=>0.01,par_max=>10,\ 
n_scan_pts=>50,log_scale=>1,...}) 
parameter_scan({parameter=>"fSyk",par_min=>0.01,par_max=>10,\ 
n_scan_pts=>50,log_scale=>1,...}) 
In	systems	such	as	the	FcεRI	model	where	crosslinking	by	a	ligand	or	scaffold	is	necessary	for	signaling,	
one	can	observe	a	phenomenon	called	high	dose	inhibition.	As	seen	in	Figure	5,	at	high	concentrations	of	
ligand,	 the	 fraction	 of	 receptors	 in	 dimers	 actually	 decreases	 to	 negligible	 values,	 and	 there	 is	 a	
corresponding	decrease	in	the	active	Syk	fraction.	This	phenomenon	occurs	because	binding	of	free	ligand	
competes	 with	 the	 crosslinking	 mechanism	 for	 free	 monomeric	 receptors,	 and	 free	 ligand	 binding	
dominates	at	high	ligand	concentrations,	leading	to	decreased	crosslinking	and	fewer	dimers	(Nag	et	al.,	
2010).	 Another	 mechanistic	 insight	 that	 can	 be	 derived	 for	 this	 system	 is	 the	 modulation	 of	 𝛾/𝛽	
phosphorylation	by	Lyn	and	Syk	numbers.	 In	 the	model,	𝛽	 sites	are	phosphorylated	by	Lyn,	as	well	as	
protected	by	Lyn-binding.	On	the	other	hand,	𝛾	sites	are	phosphorylated	by	Lyn,	but	protected	by	Syk-
binding.	As	Lyn	numbers	 increase,	the	ratio	of	𝛾/𝛽		phosphorylation	decreases,	since	more	𝛽	sites	are	
being	protected	by	Lyn-binding	(Faeder	et	al.,	2003).	Similarly,	as	Syk	numbers	increase,	the	ratio	of	𝛾/𝛽	
phosphorylation	increases,	since	more	𝛾	sites	are	being	protected	by	Syk-binding	(Faeder	et	al.,	2003).	
9. Advanced	Methods	
In	the	previous	section,	we	covered	elementary	actions	that	can	be	applied	to	BioNetGen	models,	such	as	
network	 generation	 and	 simulation	 by	ODE,	 SSA	 (Gillespie,	 1977)	 or	NFsim	 (Sneddon	 et	 al.,	 2011).	 In	
addition	to	the	basic	specification	demonstrated	in	this	chapter,	extensions	to	the	BioNetGen	language	
include	specification	of	compartments	and	transport	rules	(Harris	et	al.,	2009a),	use	of	observables	and	
local	functions	in	rate	laws	(Sneddon	et	al.,	2011)	and	preservation	of	detailed	balance	(Hogg,	2013).	In	
addition	 to	 these,	a	number	of	 improvements	 to	 simulation	algorithms	have	been	developed	 that	are	
centered	 on	 the	 BioNetGen	 specification.	 For	models	 where	 network-free	 simulation	 can	 occupy	 too	
much	memory	due	to	 large	numbers	of	certain	molecules	and	complexes,	a	hybrid	approach	between	
network-based	and	network-free	methods	can	be	used	 (Hogg	et	al.,	2014).	The	efficiency	of	each	SSA	
simulation	can	be	improved	by	enabling	tau-leaping	procedures	(Harris	et	al.,	2009b),	and	the	sampling	
of	 rare	stochastic	events	can	be	 improved	by	weighted	ensemble	simulation	(Donovan	et	al.,	2013).	A	
comprehensive	BioNetGen	actions	and	arguments	guide	is	available	at	http://bionetgen.org.		
A	number	of	external	software	have	interfaces	to	BioNetGen	or	utilize	BioNetGen	as	a	back	end.	These	
include	 modeling	 environments	 that	 facilitate	 model	 construction	 using	 programmatic,	 tabular	 or	
graphical	 interfaces,	such	as	VCell	 (Moraru	et	al.,	2008),	pySB	(Lopez	et	al.,	2013),	rxncon	(Tiger	et	al.,	
2012)	and	BioUML	(Kolpakov	et	al.,	2006).	Parameter	sensitivity	analysis	and	fitting	to	experimental	data	
can	be	performed	for	BioNetGen	models	using	the	ptempest	toolbox	for	MatLab	(Hogg,	2013)	and	the	
BioNetFit	software	(Thomas	et	al.,	2015).	Recently,	we	have	developed	advanced	visualization	tools	for	
showcasing	individual	rules	and	interactions	between	rules	(Sekar	et	al.,	n.d.),	ported	BioNetGen	model	
specification	for	the	MCell	simulator	that	explicitly	simulates	spatial	diffusion	and	reactions	(Stefan	et	al.,	
2014),	and	enabled	conversion	of	reaction	networks	to	rule-based	specifications	(Tapia	and	Faeder,	2013).	
Kappa	 (http://kappalanguage.org/) and	Simmune	 (http://simmune.org)	are	other	 rule-based	modeling	
frameworks	with	similar	rule-based	specifications	to	BioNetGen,	and	they	have	their	own	constellations	
of	related	tools	and	software.	A	common	interchange	format	SBML-Multi	is	being	developed	to	enable	
models	to	be	translated	and	analyzed	across	rule-based	frameworks	(http://sbml.org)	
10. Resources	
The	 BioNetWiki	 (http://bionetgen.org)	 is	 the	 main	 resource	 for	 all	 BioNetGen	 related	 tools.	 On	 the	
Downloads	page,	links	are	provided	for	the	standalone	BioNetGen	distribution	as	well	as	the	distribution	
bundled	with	RuleBender,	a	graphical	user	interface.	Currently,	precompiled	packages	are	distributed	for	
Windows,	OSX	and	Linux	platforms.	On	the	Tutorials	page,	one	can	find	models	that	have	been	presented	
or	published	as	parts	of	tutorials,	including	the	model	used	in	this	chapter.	For	a	comprehensive	reference	
of	BioNetGen	syntax	and	usage,	see	Faeder,	Blinov,	and	Hlavacek	(2009).	An	updated	online	version	 is	
maintained	on	the	wiki,	with	additional	documentation	on	model	visualization,	bifurcation	analysis,	tau	
leaping,	SBML	import	and	other	advanced	tools.	Also	on	the	wiki	is	a	comprehensive	reference	for	model	
actions	and	arguments	used	in	BioNetGen.	Sekar	and	Faeder	(2012)	provide	a	more	detailed	tutorial	on	
BioNetGen	that	includes	compartmental	specification	and	the	reconstruction	of	a	large	signaling	pathway.	
Chylek	et	al.	(2014)	provide	a	current	review	of	rule-based	methods	and	Chylek	et	al.	(2015)	give	examples	
that	illustrate	a	number	of	advanced	modeling	features.	The	formalisms	used	in	BioNetGen	are	explained	
in	 Blinov	 et	 al.	 (2006)	 and	 Hogg	 et	 al.	 (2014).	 For	 more	 detailed	 examples	 of	 rule-based	 models	 of	
immunoreceptor	signaling,	see	the	libraries	of	rules	for	FcεRI	(Chylek	et	al.,	2014b)	and	the	large	scale	
model	of	T	cell	receptor	signaling	(Chylek	et	al.,	2014a),	as	well	as	Chapter	14	in	this	volume.	
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Figure	Legends	
Figure	1:	Overview	of	the	FceRI	model.	(A)	Contact	Map.	This	diagram	summarizes	the	molecules,	sites	
and	binding	interactions	in	the	system.	The	ligand	has	two	identical	sites	named	fc	that	bind	the	receptor.	
The	receptor	has	alpha,	beta	and gamma	subunits,	each	modeled	as	a	site	of	the	receptor.	The	alpha	
subunit	is	used	to	bind	the	ligand,	the	beta	subunit	to	bind	Lyn	kinase,	and	gamma	subunit	to	bind	Syk	
kinase.	beta	and	gamma	subunit	have	phosphorylated	(P)	and	unphosphorylated	(0)	states	available	to	
them.	Lyn	can	bind	receptor	either	through	its	U	domain	or	its	SH2	domain.	Syk	binds	receptor	through	
its	tSH2	domain.	Syk	has	two	groups	of	phosphorylation	sites,	titled	aloop	and	linker	respectively	
which	 take	 unphosphorylated	 and	 phosphorylated	 states.	 (B)	 Transphosphorylation	 mechanisms.	
Receptors	 can	 be	 crosslinked	 to	 form	 dimers	 by	 the	 bivalent	 ligand.	 Lyn	 bound	 on	 one	 receptor	 can	
phosphorylate	beta	and	gamma	subunits	on	the	adjacent	(trans)	receptor.	Similarly,	Syk	bound	to	one	
receptor	is	phosphorylated	by	Lyn	and	Syk	bound	to	the	other.	
Figure	 2:	 Accounting	 for	 Molecules	 and	 Complexes.	 In	 the	 model,	 there	 is	 one	 type	 of	 free	 ligand	
molecule,	 and	 one	 type	 of	 free	 Lyn	 molecule	 respectively.	 Because	 sites	 can	 be	 independently	
phosphorylated,	 there	are	 four	 types	of	 free	Syk	molecules	and	 four	 types	of	 free	 receptor	molecules	
respectively.	Lyn	binding	to	free	receptor	gives	rise	to	four	Rec-Lyn	complexes.	Syk	binding	to	free	receptor	
leads	to	eight	Rec-Syk	complexes.	Syk	binding	to	Rec-Lyn	leads	to	eight	Rec-Lyn-Syk	complexes.	In	total,	
there	are	24	complexes	that	have	one	receptor	to	which	no	ligand	is	bound,	called	24	monomeric	receptor	
complexes.	When	 free	 ligand	 binds,	 this	 leads	 to	 24	 ligand-bound	monomers.	On	 crosslinked	 dimers,	
symmetry	 between	 the	 two	 recruited	monomeric	 receptors	 leads	 to	 24	 symmetric	 dimers.	When	 the	
recruited	monomeric	receptors	are	asymmetric,	there	are	276	combinations	that	are	possible,	leading	to	
276	asymmetric	dimers.	
Figure	3:	Pattern	Matching	to	Complexes.	Shown	are	three	patterns	and	matching	of	those	patterns	to	
subgraphs	within	chemical	species	(molecules	and	complexes).	The	specific	matches	are	shown	in	color	
and	the	unmatched	parts	are	grayed	out.	(A)	Pattern	Lig(fc,fc)	matching	the	one	free	ligand	species	
(red).	 (B)	Pattern	Rec(alpha)	matching	 three	complexes	with	an	unbound	alpha	domain	 (blue).	 (C)	
Pattern	Lig(fc,fc!0).Rec(alpha!0)	matching	three	complexes	in	which	one	site	of	the	ligand	is	
occupied	by	 receptor	 (green).	 In	 the	 FcεRI	model,	Rec(alpha)	matches	 all	 24	monomeric	 receptor	
complexes	and	Lig(fc,fc!0).Rec(alpha!0)	matches	all	24	ligand-bound	monomers.	
Figure	4:	Reaction	Rules.	 In	a	 reaction	 rule,	only	 the	parts	necessary	 for	a	kinetic	process	need	 to	be	
specified.	(A)	Reversible	Binding.	Reaction	rule	R1	models	reversible	binding	of	free	ligand	and	receptor.	
On	the	receptor	pattern,	only	alpha	subunit	is	specified	because	of	the	assumed	independence	between	
ligand-binding	 and	 other	 binding	 processes.	 (B)	 Transphosphorylation	 Rule.	 Reaction	 rule	 R4	models	
phosphorylation	of	beta domain	by	Lyn	recruited	to	the	adjacent	(trans)	receptor	in	a	dimer.	The	pattern	
used	indicates	the	minimum	conditions	for	this	process:	a	cross-linked	dimer,	an	unphosphorylated	beta	
domain	substrate	on	side	of	the	dimer,	and	Lyn	bound	to	beta	domain	on	the	other	side.	
Figure	 5:	 Simulation	 Results.	 Simulated	 dose-response	 curves	 from	 three	 different	 parameter	 scans	
(rows)	of	the	model.	For	each	scan,	the	outputs	measured	were	fraction	of	receptors	in	dimers,	ratio	of	
phosphorylation	 between	 𝛾	 and	 𝛽	 sites,	 and	 fraction	 of	 Syk	 that	 is	 active	 (columns).	 Varying	 ligand	
concentration	 showed	 that	dimerization	and	Syk	activation	are	 inhibited	at	high	 ligand	doses.	Varying	
Lyn/receptor	 ratio	 showed	 that	 high	 concentrations	 of	 Lyn	 protect	 𝛽	 sites	 from	 dephosphorylation.	
Varying	 Syk/receptor	 ratio	 showed	 that	 high	 concentrations	 of	 Syk	 protect	 𝛾	 sites	 from	
dephosphorylation.	
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(A) Reversible Binding Rule
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